The Latest Cardiac and Vascular News
MINNEAPOLIS, July 12, 2021 (GLOBE NEWSWIRE) — CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing, and commercializing innovative and minimally invasive neuromodulation solutions for patients with cardiovascular diseases, announces the addition of Martha Shadan to the company’s Board of Directors. With more than three decades of experience […]
Dr. Zhang has over 20 years of experience in regulatory affairs, with over a decade specifically in the field of cell and gene therapy PHILADELPHIA, July 12, 2021 (GLOBE NEWSWIRE) — Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for devastating cardiovascular and central nervous […]
The transaction will combine Hyperfine, creator of the innovative Portable MR Imaging System, Swoop™, with Liminal Sciences, a medical technology company dedicated to non-invasive brain monitoring, and HealthCor Catalio Acquisition Corp, a healthcare-focused SPAC HealthCor Management, L.P. and Catalio Capital Management teams bring decades of experience investing in private and […]
Patient’s own tissue naturally turn device into living heart valves and may reduce need for re-interventions EINDHOVEN, the Netherlands & ZURICH–(BUSINESS WIRE)–Xeltis, a clinical-stage company with the most advanced polymer-based restorative cardiovascular devices, today announced that it has started the first-ever pivotal trial for a synthetic restorative pulmonary valve. To […]
First of its Kind FDA Action Allows In-Office and At-Home Measurement for Potentially Life-Threatening Side Effect of Certain Medications MOUNTAIN VIEW, Calif., July 8, 2021 /PRNewswire/ — AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology and services, today announced it received 510(k) clearance by the U.S. Food and Drug Administration (FDA) […]
PARIS, July 08, 2021 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in developing a new drug class that directly targets the brain to treat difficult-to-treat and resistant hypertension and heart failure, today announced the enrollment of the first patient in the Company’s REFRESH study […]
Westport, CT, July 07, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced the completion of its previously […]
SAN FRANCISCO, July 08, 2021 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, and the Value Based Care Council (VBCC) of the National Association of Managed Care Physicians (NAMCP) today announced a one-of-a-kind partnership to help payers and managed care organizations (MCOs) […]
OXFORD, Ohio–(BUSINESS WIRE)–Ischemia Care today announced a new program called “CLASSICS,” which stands for Clinical Laboratory and Strategic Support to Identify Stroke and Cause of Stroke to commercialize a portfolio of hospital-based blood tests across industry leading laboratory platforms for ischemic stroke and underlying causes (such as atrial fibrillation) used in the hospital setting. According to the CDC […]
Grenoble, France, June 30, 2021 — Electroducer, the designer and developer of the innovative medical device Electroducer Sleeve® which treats heart valve disease, today announces that it has raised €3 million ($3.65M) from private investors and French public stakeholders. The funds will be used for marketing its new technology, which has been […]
